This afternoon we watched CVS Health drop -3.4% to a price of $64.97 per share. The Large-Cap Pharmaceutical Retail company is now trading -14.47% below its average target price of $75.97. Analysts have set target prices ranging from $67.0 to $90.0 per share for CVS Health, and have given the stock an average rating of buy.
The stock has a very low short interest at 1.5%, and a short ratio of 2.16. The company's insiders own 1.07% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 85.1% of CVS Health's shares being owned by this investor type.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-12-31 | Vanguard Group Inc | 9% | 117,366,367 | $7,626,466,921 |
| 2024-12-31 | Blackrock Inc. | 8% | 105,965,842 | $6,885,660,768 |
| 2024-12-31 | Dodge & Cox Inc | 6% | 70,105,899 | $4,555,481,552 |
| 2024-12-31 | Capital World Investors | 5% | 61,039,777 | $3,966,364,914 |
| 2024-12-31 | State Street Corporation | 5% | 56,952,959 | $3,700,803,467 |
| 2024-12-31 | FMR, LLC | 2% | 28,133,050 | $1,828,085,683 |
| 2024-12-31 | Geode Capital Management, LLC | 2% | 27,051,540 | $1,757,809,160 |
| 2024-12-31 | Capital International Investors | 2% | 26,666,401 | $1,732,782,826 |
| 2024-12-31 | Pzena Investment Management LLC | 2% | 19,610,579 | $1,274,295,489 |
| 2024-12-31 | NORGES BANK | 1% | 18,702,928 | $1,215,316,324 |
Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on CVS Health.
